Webinar: The Duty of Disclosure in the U.S. after Therasense

The U.S. Patent System is unique in many ways, but the peculiarity that has been the most perilous to patentees, until recently, was the trap of inequitable conduct. Pled by defendants in virtually every patent litigation, inequitable conduct, if found present, could render a valid and infringed patent completely unenforceable.

Please join our panel as they help non U.S. practitioners understand the law of inequitable conduct, including:

• Who can be accused of it and how it works;

• What the obligations are on all parties; and

• Best practices for ensuring you take advantage on the new playing field defined by Therasense.

This webinar is the first in Finnegan’s Fall 2011 series, “Strategic U.S. Patent Series for European Counsel.” We hope you are able to attend.

Moderator

Michele C. Bosch

Speakers

Bryan C. Diner

Eric P. Raciti

Time

16:00 CEST/ 10:00 AM EDT

Register

There is no charge to attend this program. Please register by October 3, 2011. Webinar access and dial-in information will be sent upon registration.